Korean J Dermatol.  2010 Feb;48(2):155-157.

A Case of Fixed Drug Eruption Induced by Tegafur-Uracil(TEGASIL)

Affiliations
  • 1Department of Dermatology, College of Medicine, Korea University, Seoul, Korea. choh@korea.ac.kr

Abstract

A mixture of tegafur and uracil (TEGASIL) is a common antineoplastic agent. Tegafur is a fluoropyrimidine structurally similar to 5-fluorouracil (5-FU); uracil slows the degradation of 5-FU by dihydropyrimidine dehydrogenase, which results in higher 5-FU concentrations in tumors. Mucocutaneous side effects induced by this agent are rare and include photosensitivity of lichenoid and eczematous types, acral erythema, hyperpigmentation and palmoplantar keratoderma. However, there have been no reports of fixed drug eruption associated with TEGASIL. We report here on a case of fixed drug eruption due to oral TEGASIL.

Keyword

Fixed drug eruption; Tegafur; Tegasil

MeSH Terms

Dihydrouracil Dehydrogenase (NADP)
Drug Eruptions
Erythema
Fluorouracil
Hyperpigmentation
Keratoderma, Palmoplantar
Tegafur
Uracil
Dihydrouracil Dehydrogenase (NADP)
Fluorouracil
Tegafur
Uracil
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr